Ischemia and Infarction

 

Epidemiology:

    • Etiologies:
      • Hypotension (global cerebral ischemia)
      • Atherosclerosis (focal cerebral ischemia)
      • Embolism:
        1. cardiac mural thrombi
          1. MI
          2. valvular disease
          3. atrial fibrillation
        2. atheroemboli from arteries:
          1. carotid
        3. paradoxical emboli:
        4. cardiac surgery-associated
        5. tumour
        6. fat / bone marrow
          1. after trauma
        7. air
      • Infectious vasculitis (usually in setting of immunosuppression):
        1.  toxoplasmosis
        2. aspergillosis
        3. CMV encephalitis
      • Vasculitis :
        1. Polyarteritis nodosa
        2. primary angiitis of the central nervous system
        3. other colagen vascular diseases
      • hypercoagulable states
      • dissecting aneurysm of extracranial arteries supplying the brain
      • drug abuse
        1. amphetamines
        2. heroin
        3. cocaine
      • Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
        1. Notch3 mutations
      • Cerebral amyloid angiopathy (CAA)
        1. apoE genotype (epsilon-2 or epsilon-4 allele) increases risk of recurrence of hemorrhage in sporadic CAA
        2. sporadic or familial

 

Common sites:

    •  global cerebral ischemia (most susceptible regions):
      • hippocampus (Pyramidal neurons of the Sommer sector (CA1)
      • cerebellum (Purkinje cells)
      • neocortex (Pyramidal neurons)
        1. watershed zone a few cm lateral to interhemispheric fissure (between anterior and middle cerebral artery distributions)
    • focal cerebral ischemia:
      • areas with least collaterals (deep penetrating vessels):
        1. thalamus
        2. basal ganglia
        3. deep white matter
      • atherosclerosis:
        1. carotid bifurcation
        2. origin of middle cerebral a.
        3. either end of the basilar a.
    • embolism:
      • MCA distribution
      • Fat / bone marrow:
        1. “shower embolization” – widespread hemorrhagic lesions involving white matter

 

Gross features:

    • Global cerebral ischemia:
      • Swollen brain
        • Widened gyri
        • Narrowed sulci
      • Indistinct corticomedullary junction
    • Focal cerebral ischemia:
      • Non-hemorrhagic infarction:
        • <6h:
          1. little can be observed
        • 48 hours:
          1. pale
          2. soft
          3. swollen
          4. indistinct corticomedullary junction
        • 2-10 days:
          1. gelatinous
          2. friable
          3. more distinct border on uninvolved tissue
        • 10 days – 3 weeks:
          1. liquefaction of infarcted area
          2. fluid-filled cavity lined by dark gray tissue
          3. eventual removal of dead tissue

 

Histologic features:

    •  early (12-24h):
      • acute neuronal injury
      • cytotoxic and vasogenic edema
      • decreased myelin staining (increased edema?)
      • similar changes in astrocytes and oligodendroglia (later)
    • 24-48h
      • neutrophil infiltration starting at the edges of the lesion
    • subacute (48h – 2 weeks):
      • tissue necrosis
      • macrophage infiltration
      • vascular proliferation
      • reactive gliosis
    • repair (> 2weeks):
      • macrophages still present (may persist for months to years)
      • removal of necrotic tissue
        • pseudolaminar necrosis (preservation of some layers and not others)
      • loss of normal CNS structure
      • gliosis
    • > several months:
      • receding of astrocytic nuclear and cytoplasmic enlargement
      • wall of cavity shows dense feltwork of glial fibers and new capillaries and perivascular connective tissue fibres
    • hemorrhagic infarction:
      • addition of blood extravasation and resorption
    • incomplete infarction:
      • selective necrosis of neurons

 

Immunophenotype:

Marker:

Sensitivity:

Specificity:

 

 

 

 

Molecular features:

    •  

 

Other features:

    •  

 

References:

    •  Robbins & Cotran Pathologic Basis of Disease (2005)